All of which are directly impacted by how we fund the system.
1. We lead the world in transitioning from inpatient to outpatient care; for instance, I read a source last night that said the majority of hernia repairs in the NHS were inpatient, and the overwhelming majority of them in the US were outpatient. That's good, but an unintended consequence of it is that it's easier to route a patient to a surgical procedure if it's done outpatient, and as a consequence US patients get a lot more of these procedures, some of them (cardiac stents being a recent well-publicized example) of dubious utility. Our relative overconsumption of services doesn't lead to better outcomes, and thus represents misallocation.
2. Our health provider systems are more decentralized, delivered in smaller clinics and hospitals. Our hospitals generally, nationwide, have poor utilization. Not only do we therefore overspend on plant and salary costs (which we do, relative to Europe) but coupled with our price transparency problems we end up with the situation Atul Gawande described a year or two back, when he noted the insane difference in prices for an MRI at different imaging centers in a small region of (iirc) Texas.
Our system right now isn't good and some of it (but by no means all of it) is related to how we regulate the way it's funded. But Medicare overspends on many of the same things. The structural problems will need to be corrected no matter how we design the rest of the system.
Ultimately I think the problem in the US is a sort of perfect storm of badnesses.
(Good sources: Kauffman's health cost explorer, the McKinsey report, the Health Care Cost Institute annual breakdowns).
In the first instance it's a tension between the providers trying to maximize service, insurers trying to minimize risk and the user having little agency in the outcome.
The second example is a straight up agency problem.
None of that changes the argument, it is a perfect storm of badness and even if nationalized healthcare was politically feasible it wouldn't fix all of these issues.
I just want to get to the point where my insurance doesn't come from my employer...
Medicare is not a single payer system, but a partial-subsidy voucher system for highly-regulated private insurance with (for the core inpatient and outpatient components) a fully-paid public option.
As for the private options do any of them have the weird employer provided health care indirection?
The fact that one of the major players in the funding space have an intermediary as a customer instead of the health care recipient is a further distortion of the market.
Imagine if we got our car insurance the way we get our health insurance. What impact would that have on efficiency of that industry?
It's possible that the pathologies of our system created those other structural flaws; like, if we had an NHS instead of private insurers, we wouldn't have built all these inefficient hospitals. But whatever the cause, we are where we are, and switching to single payer won't undo those problems.
Which sums up my concern about single-payer: it might be a good way to lock in a lot of structural problems for a long time. Meanwhile, if you just directly address the problems themselves --- stabilize the markets, enact strong price transparency rules, aggressively incentivize efficiency --- you might not need single-payer (an immense, disruptive change) in the first place.
Also, if we want cost outcomes approaching that of the NHS, we have to do more than simply enact single-payer. We also have to aggressively set rates, reduce compensation for doctors, fire a lot of nurses, and make people wait years for knee surgery.
Further, it’s a less dramatic thing to change. We’ve already been through a much more impactful change in living memory in the form of moving away from pensions.
My position is that changing that are of funding brings price transparency to the biggest segment of the population & it derisks the migration.
Medicare isn't a closed system, and isn't the majority of funding, so it has to deal with the structural results of the rest of the system, which is majority private pay (and heck, Medicare itself is a partially-subsidized private-insurance voucher system with a public option for it's core services, which exclude prescription drug coverage, which is provided through an optional partially-subsidized private voucher with no public option.)
(I asked roughly the same question upthread a few minutes earlier, so if you answer there, I'll see that answer and consider it an answer to this question too. Thanks!)